True Wealth Design’s Rocket Pharmaceuticals RCKT Stock Holding History

True Wealth Design’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$692	Sell	263 -610	-70%	-$2.11K	﹤0.01%	2040
2026 Q2	$2.99K	Buy	873 +171	+24%	+$569	﹤0.01%	1540
2026 Q1	$2.51K	Buy	702 +492	+234%	+$1.96K	﹤0.01%	1449
2025 Q4	$738	Hold	210	–	–	﹤0.01%	1823
2025 Q3	$685	Buy	+210	New	+$661	﹤0.01%	1897

Other funds holding RCKT

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

True Wealth Design's RCKT Position: Q3 2026 in Review

True Wealth Design reduced its Rocket Pharmaceuticals (RCKT) stake by 70% in Q3 2026, selling an estimated $2.11K and leaving 263 shares worth $692. The position accounts for ﹤0.01% of the portfolio, ranked #2040.

True Wealth Design first reported a position in RCKT in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.99K in Q2 2026. 10 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

True Wealth Design held 263 shares of Rocket Pharmaceuticals worth $692 as of Q3 2026.
True Wealth Design sold 610 Rocket Pharmaceuticals shares in Q3 2026, an estimated $2.11K.
Rocket Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2040 holding.
True Wealth Design first reported a position in Rocket Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
True Wealth Design's Rocket Pharmaceuticals position peaked at $2.99K in Q2 2026.
10 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.